Effects of Gender-Affirming Hormone Therapy on Insulin Sensitivity and Incretin Responses in Transgender People.
Samyah ShadidKessewa Abosi-AppeaduAnne-Sophie De MaertelaereJustine DefreyneLaurens VeldemanJens Juul HolstBruno LapauwTina VilsbøllGuy T'SjoenPublished in: Diabetes care (2019)
In this cohort of transgender persons, insulin sensitivity but also post-OGTT incretin responses tend to increase with masculinization and to decrease with feminization.